You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ras Pathway Alterations

Showing 1 - 25 of 5,884
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

Suspended
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Boston, Massachusetts
  • +2 more
Oct 5, 2022

Malignant Tumor of Breast, Malignant Tumors of Digestive Organs, Malignant Tumors of Female Genital Organs Trial in Houston

Recruiting
  • Malignant Neoplasm of Breast
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 29, 2021

Advanced Solid Tumors Harboring MAPK Pathway Alterations Trial in Shandong (QLH11906)

Recruiting
  • Advanced Solid Tumors Harboring MAPK Pathway Alterations
  • Shandong, China
    Shandong Cancer Hospital
Aug 3, 2022

Advanced Cancer, Metastatic Cancer, Solid Tumor Trial in United States (JZP815)

Recruiting
  • Advanced Cancer
  • +2 more
  • Denver, Colorado
  • +4 more
Jan 10, 2023

RAS Mutation, NRAS Gene Mutation, Melanoma Trial in Phoenix, Newnan, Zion (OKI-179 + binimetinib)

Recruiting
  • RAS Mutation
  • +2 more
  • OKI-179 + binimetinib
  • Phoenix, Arizona
  • +4 more
Sep 22, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Recurrent Ovarian Carcinoma
  • Biopsy
  • +5 more
  • (no location specified)
Sep 29, 2022

Circulating Tumour DNA Testing in Assessing for Alterations of

Recruiting
  • Colorectal Cancer
    • Singapore, Singapore
      National University Hospital
    Sep 28, 2021

    Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

    Completed
    • Colorectal Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    May 12, 2022

    Resistance-associated Mutations in Metastatic Lung Cancer

    Recruiting
    • Lung Cancer
    • Liquid biopsy
    • Monza, MB, Italy
      Fondazione IRCCS San Gerardo dei Tintori
    Oct 10, 2023

    Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

    Recruiting
    • Refractory Cancer
    • +14 more
    • Atlanta, Georgia
    • +1 more
    Oct 23, 2023

    Low-Grade Gliomas, Malignant Tumors, Brain, Soft Tissue Tumors Trial in United States (MEK162)

    Active, not recruiting
    • Low-Grade Gliomas
    • +2 more
    • Birmingham, Alabama
    • +14 more
    Jan 25, 2023

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Proteus Syndrome, PIK3CA-Related Overgrowth Spectrum (PROS), Growth Disorders Trial (ARQ 092)

    No longer available
    • Proteus Syndrome
    • +2 more
    • ARQ 092
    • (no location specified)
    Jul 31, 2021

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Dec 13, 2022

    Castration-resistant Prostate Cancer, Metastasis Trial in France (Carboplatin)

    Terminated
    • Castration-resistant Prostate Cancer
    • Metastasis
    • Caen, France
    • +3 more
    Apr 28, 2021

    Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Retroperitoneal Sarcoma AJCC v8 Trial in Columbus

    Not yet recruiting
    • Locally Advanced Leiomyosarcoma
    • +6 more
    • Niraparib Tosylate Monohydrate
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jul 25, 2022

    Migraine Trial in Saint Louis (device, behavioral, diagnostic test, other)

    Recruiting
    • Migraine
    • Thermal stimuli
    • +7 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 20, 2023

    Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

    Not yet recruiting
    • Breast Cancer
    • Marseille, France
      Institut Paoli Calmettes
    Aug 9, 2023

    Metastatic Malignant Tumor to Brain Trial in Boston (Palbociclib)

    Recruiting
    • Metastatic Malignant Neoplasm to Brain
    • Boston, Massachusetts
    • +1 more
    Oct 25, 2021

    Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

    Not yet recruiting
    • Recurrent Biliary Tract Carcinoma
    • +13 more
    • (no location specified)
    Nov 8, 2022

    Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

    Recruiting
    • Melanoma
    • Solid Tumor
    • Los Angeles, California
    • +13 more
    Jul 27, 2022

    Colorectal Cancer Trial in Milano, Candiolo, Padova (Panitumumab 20 MG/ML Intravenous Solution [VECTIBIX], Molecular Screening)

    Active, not recruiting
    • Colorectal Cancer
    • Panitumumab 20 MG/ML Intravenous Solution [VECTIBIX]
    • Molecular Screening
    • Milano, Via Giacomo Venezian, 1, Italy
    • +3 more
    Aug 26, 2021

    Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

    Not yet recruiting
    • Advanced or Metastatic Solid Tumors
    • (no location specified)
    Jun 21, 2023